Cam Gallagher
President & Chief Executive Officer at Alessa Therapeutics
Scottsdale, Arizona, United States
Find your path to Cam
218 people in our graph share verified history with Cam — schools, employers, funds. One of them is your warm intro.
About
Cam Gallagher is President and Chief Executive Officer of Alessa Therapeutics, Inc., a clinical-stage drug development company working on a localized drug delivery technology for the early treatment of prostate cancer. He has over 35 years of experience in the biotechnology and pharmaceutical industries and previously co-founded Zentalis Pharmaceuticals (NASDAQ: ZNTL), where he served as President, interim CFO, and board member. He currently sits on the boards of Opus Genetics (Nasdaq: IRD), Crosslink Therapeutics, and UC San Diego Health – Moores Cancer Center, and has held prior board roles at VelosBio, Retrosense Therapeutics, Zentalis Pharmaceuticals, and Immusoft.
President & Chief Executive Officer at Alessa Therapeutics
Intro paths
In turn, Cam can intro founders to Alessa Therapeutics's investors below.
Alessa Therapeutics's investors · 4
Co-founders at Alessa Therapeutics

Experience
- Alessa Therapeutics, Inc.President & Chief Executive Officercurrent2024 — presentSan Francisco Bay Area
- Opus GeneticsChairman of the Board of Directorscurrent2020 — presentDurham, NC
- Crosslink TherapeuticsChairman of the Board of Directorscurrent2025 — presentBoston, Massachusetts, United States
- Velosity CapitalGeneral Partnercurrent2021 — presentSan Diego, California, United States
- SelectION, Inc.Founding Board Member2018 — 2026San Diego, CA
- Zentalis PharmaceuticalsCo-Founder, President & Board Member2014 — 2024San Diego, California, United States
- Ray Therapeutics, Inc.Co-Founder, Board Member2021 — 2023San Francisco, California, United States
- VelosBio, Inc. (acquired by Merck for $2.75B)Founding Board Member2017 — 2020Seattle, WA
- Oncternal TherapeuticsBoard Member2016 — 2019San Diego, CA
- Zavante Therapeutics, Inc. (acquired by Nabriva Therapeutics)Co-Founder & Chief Business Officer2014 — 2018San Diego, CA
- RetroSense Therapeutics (acquired by Allergan for up to $580M)Chief Business Officer & Board Member2014 — 2016Ann Arbor, MI & San Diego, CA
- Dura Pharma (acquired by Elan for $1.8B), CV Therapeutics & Verus PharmaVarious Commercial Sales & Marketing Positions1992 — 2007San Diego & San Francisco
Skills & more
+10 more
Medical DevicesMarketing StrategyOncologySales OperationsBusiness DevelopmentSellingHealthcareNew Restaurant OpeningsSelling SkillsSales EffectivenessFrom Cam's professional profile.
Frequently asked questions
- Who is Cam Gallagher?
- Cam Gallagher is President and Chief Executive Officer of Alessa Therapeutics, Inc., a clinical-stage drug development company working on a localized drug delivery technology for the early treatment of prostate cancer. He has over 35 years of experience in the biotechnology and pharmaceutical industries and previously co-founded Zentalis Pharmaceuticals (NASDAQ: ZNTL), where he served as President, interim CFO, and board member. He currently sits on the boards of Opus Genetics (Nasdaq: IRD), Crosslink Therapeutics, and UC San Diego Health – Moores Cancer Center, and has held prior board roles at VelosBio, Retrosense Therapeutics, Zentalis Pharmaceuticals, and Immusoft.
- Where does Cam Gallagher work?
- Cam Gallagher is President & Chief Executive Officer at Alessa Therapeutics.
- Where did Cam Gallagher go to school?
- Cam Gallagher studied at University of San Diego (M.B.A., Marketing & Finance); Ohio University (Bachelor of Business Administration, Marketing & Finance).
Same school
Also attended University of San Diego120
+ 114 more
Also attended Ohio University86
+ 80 more
Shared employers
Also worked at Alessa Therapeutics, Inc.4
Also worked at Opus Genetics9
+ 3 more
























